Association of adiponectin gene polymorphism with adiponectin levels and risk for insulin resistance syndrome

Jai Prakash, Balraj Mittal, Shally Awasthi, Neena Srivastava, Jai Prakash, Balraj Mittal, Shally Awasthi, Neena Srivastava

Abstract

Background: Adiponectin is an abundant adipose tissue-derived protein with anti-atherogenic, anti-inflammatory and antidiabetic properties. Plasma adiponectin levels are decreased in obesity, type 2 diabetes, and coronary artery disease and low adiponectin levels also predict insulin resistance (IR).

Methods: Case-control study in which 642 male and female subjects were participated from the North Indian population. Lipid, insulin, leptin and adiponectin level were estimated using standard protocols by commercially available test kits. Single nucleotide polymorphisms +45T>G and +276G>T of the AMP1 (adiponectin) gene was genotyped by polymerase chain reaction restriction fragment length polymorphism method.

Results: Levels of adiponectin, insulin, homeostasis model assessment-IR index (HOMA-IR index), systolic blood pressure and fat mass showed significant differences between male and female subjects. Serum adiponectin level showed highly significant association with both the +45 and the +276 genotypes. The common haplotype triglyceride (TG) showed a significantly lower adiponectin value than other haplotypes (P = 0.0001). A clear trend of decreasing adiponectin levels per copy of the common haplotype was observed. Nonobese insulin sensitive subjects showed a higher adiponectin value (P = 0.0006) than nonobese insulin resistant subjects. The values of blood pressure, adiponectin, insulin, HOMA-IR, total-cholesterol, and low-density lipoprotein-cholesterol significantly associated with TG haplotype.

Conclusions: We observed the very strong association of the adiponectin 45-276 genotypes and haplotypes with adiponectin levels in healthy north Indian population and TG haplotypes also associated with metabolic parameters of the IR syndrome.

Keywords: AMP1; Adiponectin; haplotype; insulin resistance; polymorphism.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, et al. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res Int 2014. 2014 658913.
    1. Arikoglu H, Ozdemir H, Kaya DE, Ipekci SH, Arslan A, Kayis SA, et al. The adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population. Gene. 2014;534:10–16.
    1. Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: A critical component in human diseases. Int J Mol Sci. 2014;16:378–400.
    1. Francke S, Manraj M, Lacquemant C, Lecoeur C, Leprêtre F, Passa P, et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet. 2001;10:2751–65.
    1. Xita N, Tsatsoulis A. Adiponectin in diabetes mellitus. Curr Med Chem. 2012;19:5451–8.
    1. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815–9.
    1. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin – A key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006;8:264–80.
    1. Zhang C, Luo H, Gao F, Zhang CT, Zhang R. A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program. Acta Diabetol. 2014 doi: 10.1007/s00592-014-0655-2.
    1. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A. 2000;97:14478–83.
    1. Vionnet N, Hani EH, Dupont S, Gallina S, Francke S, Dotte S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet. 2000;67:1470–80.
    1. Li P, Jiang R, Li L, Liu C, Yang F, Qiu Y. Correlation of serum adiponectin and adiponectin gene polymorphism with metabolic syndrome in Chinese adolescents. Eur J Clin Nutr. 2015;69:62–7.
    1. Cheung CY, Hui EY, Cheung BM, Woo YC, Xu A, Fong CH, et al. Adiponectin gene variants and the risk of coronary heart disease: A 16-year longitudinal study. Eur J Endocrinol. 2014;171:107–15.
    1. Ramya K, Ayyappa KA, Ghosh S, Mohan V, Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene. 2013;532:253–62.
    1. Daniele A, Cammarata R, Pasanisi F, Finelli C, Salvatori G, Calcagno G, et al. Molecular analysis of the adiponectin gene in severely obese patients from southern Italy. Ann Nutr Metab. 2008;53:155–61.
    1. Lu JF, Zhou Y, Huang GH, Jiang HX, Hu BL, Qin SY. Association of ADIPOQ polymorphisms with obesity risk: A meta-analysis. Hum Immunol. 2014;75:1062–8.
    1. Sabouri S, Ghayour-Mobarhan M, Moohebati M, Hassani M, Kassaeian J, Tatari F, et al. Association between 45T/G polymorphism of adiponectin gene and coronary artery disease in an Iranian population. Scientific World Journal. 2011;11:93–101.
    1. El-Shal AS, Zidan HE, Rashad NM. Adiponectin gene polymorphisms in Egyptian type 2 diabetes mellitus patients with and without diabetic nephropathy. Mol Biol Rep. 2014;41:2287–98.
    1. Yan CJ, Li SM, Xiao Q, Liu Y, Hou J, Chen AF, et al. Influence of serum adiponectin level and SNP +45 polymorphism of adiponectin gene on myocardial fibrosis. J Zhejiang Univ Sci B. 2013;14:721–8.
    1. Nikolajevic-Starcevic J, Pleskovic A, Santl Letonja M, Jenko Pražnikar Z, Petrovic D. Polymorphisms +45T>G and +276G>T of the adiponectin gene does not affect plasma adiponectin level and carotid intima-media thickness in patients with diabetes mellitus type 2. Int Angiol. 2014;33:434–40.
    1. Prakash J, Mittal B, Awasthi S, Agarwal CG, Srivastava N. K121Q ENPP1/PC-1 gene polymorphism is associated with insulin resistance in a North Indian population. J Genet. 2013;92:571–6.
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
    1. Young DS, Pestaner LC, Gibberman V. Effects of drugs on clinical laboratory tests. Clin Chem. 1975;21:1D–432D.
    1. Parker D, Liu K, Dyer AR, Giumetti D, Liao YL, Stamler J. A comparison of the random-zero and standard mercury sphygmomanometers. Hypertension. 1988;11:269–72.
    1. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
    1. Yoo J, Seo B, Kim Y. SNPAnalyzer: A web-based integrated workbench for single-nucleotide polymorphism analysis. Nucleic Acids Res. 2005;33:W483–8.
    1. Mente A, Meyre D, Lanktree MB, Heydarpour M, Davis AD, Miller R, et al. Causal relationship between adiponectin and metabolic traits: A Mendelian randomization study in a multiethnic population. PLoS One. 2013;8:e66808.
    1. Gupta AC, Misra R, Sakhuja P, Singh Y, Basir SF, Sarin SK. Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease. Gene. 2012;496:63–7.
    1. Ong KL, Li M, Tso AW, Xu A, Cherny SS, Sham PC, et al. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol. 2010;163:251–7.
    1. Chung HK, Chae JS, Hyun YJ, Paik JK, Kim JY, Jang Y, et al. Influence of adiponectin gene polymorphisms on adiponectin level and insulin resistance index in response to dietary intervention in overweight-obese patients with impaired fasting glucose or newly diagnosed type 2 diabetes. Diabetes Care. 2009;32:552–8.
    1. Youpeng B, Wei X, Wei L, Jin J, Haiyan Y, Yuan Y, et al. Relationships among adiponectin gene polymorphisms, proteinuria and increased blood pressure in the context of placental diseases. Hypertens Res. 2010;33:1066–70.
    1. Demirci H, Yilmaz M, Ergun MA, Yurtcu E, Bukan N, Ayvaz G. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters. Gynecol Endocrinol. 2010;26:348–55.
    1. Sanghera DK, Demirci FY, Been L, Ortega L, Ralhan S, Wander GS, et al. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism. 2010;59:492–501.
    1. Prakash J, Srivastava N, Awasthi S, Agarwal CG, Natu SM, Rajpal N, et al. Association of FTO rs17817449 SNP with obesity and associated physiological parameters in a north Indian population. Ann Hum Biol. 2011;38:760–3.
    1. Livshits G, Malkin I, Moayyeri A, Spector TD, Hammond CJ. Association of FTO gene variants with body composition in UK twins. Ann Hum Genet. 2012;76:333–41.
    1. Malhotra A, Igo RP, Jr, Thameem F, Kao WH, Abboud HE, Adler SG, et al. Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations-significant evidence for linkage on chromosome 4q in African Americans: The Family Investigation of Nephropathy and Diabetes Research Group. Diabetes Metab Res Rev. 2009;25:740–7.
    1. Biswas D, Vettriselvi V, Choudhury J, Jothimalar R. Adiponectin gene polymorphism and its association with type 2 diabetes mellitus. Indian J Clin Biochem. 2011;26:172–7.
    1. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002;51:2306–12.
    1. Mackevics V, Heid IM, Wagner SA, Cip P, Doppelmayr H, Lejnieks A, et al. The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur J Hum Genet. 2006;14:349–56.
    1. Prakash J, Mittal B, Awasthi S, Agarwal CG, Srivastava N. Hypoadiponectinemia in obesity: Association with insulin resistance. Indian J Clin Biochem. 2013;28:158–63.
    1. Huang Y, Li Y, Chen Q, Chen H, Ma H, Su Z, et al. Low serum adiponectin levels are associated with reduced insulin sensitivity and lipid disturbances in short children born small for gestational age. Clin Endocrinol (Oxf) 2014 doi: 10.1111/cen.12663.
    1. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277:25863–6.
    1. Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002;103:137–42.
    1. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8:731–7.
    1. Ramirez VI, Miller E, Meireles CL, Gelfond J, Krummel DA, Powell TL. Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers. BMJ Open Diabetes Res Care. 2014;2:e000010.
    1. Melistas L, Mantzoros CS, Kontogianni M, Antonopoulou S, Ordovas JM, Yiannakouris N. Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. Eur J Endocrinol. 2009;161:845–52.
    1. Gaens KH, Goossens GH, Niessen PM, van Greevenbroek MM, van der Kallen CJ, Niessen HW, et al. Ne-(carboxymethyl) lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance. Arterioscler Thromb Vasc Biol. 2014;34:1199–208.
    1. Prakash J, Srivastava N, Awasthi S, Agarwal C, Natu S, Rajpal N, et al. Association of PPAR-g gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population. Am J Hum Biol. 2012;24:454–9.
    1. Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH, et al. Hypoadiponectinemia as a predictor for the development of hypertension: A 5-year prospective study. Hypertension. 2007;49:1455–61.
    1. de Faria AP, Demacq C, Figueiredo VN, Moraes CH, Santos RC, Sabbatini AR, et al. Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension. Hypertens Res. 2013;36:1067–72.
    1. Imatoh T, Miyazaki M, Momose Y, Tanihara S, Une H. Adiponectin levels associated with the development of hypertension: A prospective study. Hypertens Res. 2008;31:229–33.
    1. Blüher M, Michael MD, Peroni OD, Ueki K, Carter N, Kahn BB, et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell. 2002;3:25–38.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren